HIGHLIGHTS
- who: Edward Yu from the CanadaUniversity, Richmond Street, London, Ontario N A, Canada Canada have published the research: Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trial, in the Journal: (JOURNAL)
- what: Blood samples and CTC detection For this study based on a secondary correlative analysis of CTCs, only OS and DFS secondary endpoints were examined and reported.
SUMMARY
Patients with CTCs detected at any follow-up visits vs. no CTCs had . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.